U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06874231) titled 'Brain Connectivity Marker for Alzheimer's Disease' on April 04, 2023.
Brief Summary: The main purpose of this project is to establish whether changes in brain connectivity can be used to predict the development of Alzheimer's disease (AD).
Study Start Date: April 01, 2023
Study Type: OBSERVATIONAL
Condition:
Alzheimer Disease
Intervention:
OTHER: Neuroimaging
We will collect imaging sequence, cognitive test scores, clinical data and biofluid samples
Recruitment Status: RECRUITING
Sponsor: Karolinska Institutet
Information provided by (Responsible Party): Joana Braga Pereira, Karolinska Institutet
Disclaimer: Curated by H...